We compared morphological indexes of CD44+ CRC from 8 chemotherapy-naive cancer samples representing the true-positive samples and counting 79 cells with all 12 non-malignant afflicted samples including healthy cohort representing the true negative cohort and counting 80 cells. This evidence concerns the gene CD44 and colorectal carcinoma.